117 related articles for article (PubMed ID: 24067866)
61. Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
Marconi P; Tamura M; Moriuchi S; Krisky DM; Niranjan A; Goins WF; Cohen JB; Glorioso JC
Mol Ther; 2000 Jan; 1(1):71-81. PubMed ID: 10933914
[TBL] [Abstract][Full Text] [Related]
62. [Suicide gene therapy for glioma using HSV-tk/GCV system].
Xu L; Ge K; Zheng Z
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):353-7. PubMed ID: 10920915
[TBL] [Abstract][Full Text] [Related]
63. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
[TBL] [Abstract][Full Text] [Related]
64. Similar efficiency of DNA-liposome complexes and retrovirus-producing cells for HSV-tk suicide gene therapy of peritoneal carcinomatosis.
Princen F; Lechanteur C; Lopez M; Gielen J; Bours V; Merville MP
J Drug Target; 2000; 8(2):79-89. PubMed ID: 10852340
[TBL] [Abstract][Full Text] [Related]
65. Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study.
Harsh GR; Deisboeck TS; Louis DN; Hilton J; Colvin M; Silver JS; Qureshi NH; Kracher J; Finkelstein D; Chiocca EA; Hochberg FH
J Neurosurg; 2000 May; 92(5):804-11. PubMed ID: 10794295
[TBL] [Abstract][Full Text] [Related]
66. Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration.
Klatzmann D
Hum Gene Ther; 1996 Jan; 7(2):255-67. PubMed ID: 8788175
[TBL] [Abstract][Full Text] [Related]
67. A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy.
Hakkarainen T; Hemminki A; Curiel DT; Wahlfors J
Int J Mol Med; 2006 Oct; 18(4):751-9. PubMed ID: 16964432
[TBL] [Abstract][Full Text] [Related]
68. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
69. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.
Sutton MA; Freund CT; Berkman SA; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Lerner SP
Mol Ther; 2000 Sep; 2(3):211-7. PubMed ID: 10985951
[TBL] [Abstract][Full Text] [Related]
70. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
[TBL] [Abstract][Full Text] [Related]
71. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
72. Use of protamine to augment adenovirus-mediated cancer gene therapy.
Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
[TBL] [Abstract][Full Text] [Related]
73. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene.
Nagy HJ; Panis Y; Fabre M; Klatzmann D; Houssin D; Soubrane O
Anticancer Res; 2000; 20(6B):4633-8. PubMed ID: 11205314
[TBL] [Abstract][Full Text] [Related]
74. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
Ulasov IV; Sonabend AM; Nandi S; Khramtsov A; Han Y; Lesniak MS
Br J Cancer; 2009 Apr; 100(7):1154-64. PubMed ID: 19277041
[TBL] [Abstract][Full Text] [Related]
75. Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.
Mangraviti A; Tzeng SY; Kozielski KL; Wang Y; Jin Y; Gullotti D; Pedone M; Buaron N; Liu A; Wilson DR; Hansen SK; Rodriguez FJ; Gao GD; DiMeco F; Brem H; Olivi A; Tyler B; Green JJ
ACS Nano; 2015 Feb; 9(2):1236-49. PubMed ID: 25643235
[TBL] [Abstract][Full Text] [Related]
76. Detection of lentiviral suicide gene therapy in C6 rat glioma using hyperpolarised [1-
Nivajärvi R; Olsson V; Hyppönen V; Bowen S; Leinonen HM; Lesch HP; Ardenkjaer-Larsen JH; Gröhn OHJ; Ylä-Herttuala S; Kettunen MI
NMR Biomed; 2020 Apr; 33(4):e4250. PubMed ID: 31909530
[TBL] [Abstract][Full Text] [Related]
77. Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.
Hojeij R; Domingos-Pereira S; Nkosi M; Gharbi D; Derré L; Schiller JT; Jichlinski P; Nardelli-Haefliger D
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428950
[TBL] [Abstract][Full Text] [Related]
78. Combined delivery of temozolomide and the thymidine kinase gene for treatment of glioblastoma.
Choi E; Han J; Tan X; Oh J; Lee D; Rhim T; Lee M
J Drug Target; 2017 Feb; 25(2):156-162. PubMed ID: 27401451
[TBL] [Abstract][Full Text] [Related]
79. Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model.
Dagıstan Y; Karaca I; Bozkurt ER; Ozar E; Yagmurlu K; Toklu A; Bilir A
Acta Cir Bras; 2012 Jun; 27(6):383-7. PubMed ID: 22666755
[TBL] [Abstract][Full Text] [Related]
80. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide.
Hingtgen S; Ren X; Terwilliger E; Classon M; Weissleder R; Shah K
Mol Cancer Ther; 2008 Nov; 7(11):3575-85. PubMed ID: 19001440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
